Johnson & Johnson MedTech (NYSE: JNJ) announced today that the FDA cleared its Monarch Quest technology for robotic-assisted ...

Johnson & Johnson MedTech (NYSE: JNJ) announced new regulatory nods for multiple orthopedic technology offerings.

Johnson & Johnson MedTech said Wednesday its Monarch Quest robotic platform received clearance from the Food and Drug ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

A depression drug candidate that’s a key part of Johnson & Johnson’s neuroscience strategy has failed a Phase 3 clinical trial, the latest dose of disappointing news for an emerging class of ...

Dr. Marty Makary, President Donald Trump's choice to lead the Food and Drug Administration, pointed out the Biden ...

Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

This summary highlights key global health developments, including J&J halting studies of a depression drug due to low ...

Delaware State Police have arrested two men on felony drug charges following a vehicle pursuit and crash near Millsboro on ...

According to the Hoke County Sheriff’s Office, the Narcotic/Vice Suppression Unit served a search warrant in the 100 block of ...